The anticancer antibiotic mithramycin-A inhibits TRPV1 expression in dorsal root ganglion neurons

Neuroscience Letters

Volumn 578, Issue , 2014, Pages 211-216

  Zavala, K ^a   Lee, J ^a   Chong, J ^a   Sharma, M ^a   Eilers, H ^a   Schumacher, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticancer; Mithramcyin A; Nociceptor; Pain; TRPV1

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ANTIPRURITIC AGENT; CAPSAICIN; MESSENGER RNA; MITHRAMYCIN; MITHRAMYCIN A; SP4 PROTEIN, RAT; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP4; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; METABOLISM; NERVE CELL; PRIMARY CELL CULTURE; RAT; SPINAL GANGLION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIPRURITICS; CAPSAICIN; GANGLIA, SPINAL; NEURONS; PLICAMYCIN; PRIMARY CELL CULTURE; RATS; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; SP4 TRANSCRIPTION FACTOR; TRPV CATION CHANNELS;

EID: 84905096700     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.021     Document Type: Note

References (35)

1. Rao K.V., Cullen W.P., Sobin B.A. A new antibiotic with antitumor properties. Antibiot. Chemother. 1962, 12:182-186.
2. Yarbro J.W., Kennedy B.J., Barnum C.P. Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res. 1966, 26(1):36-39.
3. Baguley B.C. Nonintercalative DNA-binding antitumour compounds. Mol. Cell. Biochem. 1982, 43(3):167-181.
4. Blume S.W., Snyder R.C., Ray R., Thomas S., Koller C.A., Miller D.M. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin. Invest. 1991, 88(5):1613-1621.
5. Snyder R.C., Ray R., Blume S., Miller D.M. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 1991, 30(17):4290-4297.
6. Campbell V.W., Davin D., Thomas S., Jones D., Roesel J., Tran-Patterson R., Mayfield C.A., Rodu B., Miller D.M., Hiramoto R.A. The G-C specific DNA binding drug: mithramycin, selectively inhibits transcription of the C-MYC and C-HA-RAS genes in regenerating liver. Am. J. Med. Sci. 1994, 307(3):167-172.
7. Remsing L.L., Bahadori H.R., Carbone G.M., McGuffie E.M., Catapano C.V., Rohr J. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target. Biochemistry 2003, 42(27):8313-8324.
8. Brown J.H., Kennedy B.J. Mithramycin in the treatment of disseminated testicular neoplasms. N. Engl. J. Med. 1965, 272:111-118.
9. Edwards C.R., Besser G.M. Mithramycin treatment of malignant hypercalcaemia. Br. Med. J. 1968, 3(5611):167-168.
10. Ryan W.G., Schwartz T.B., Perlia C.P. Effects of mithramycin on Paget's disease of bone. Ann. Intern. Med. 1969, 70(3):549-557.
11. Chu C., Zavala K., Fahimi A., Lee J., Xue Q., Eilers H., Schumacher M.A. Transcription factors Sp1 and Sp4 regulate TRPV1 gene expression in rat sensory neurons. Mol. Pain 2011, 7:44.
12. Xue Q., Jong B., Chen T., Schumacher M.A. Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J. Neurochem. 2007, 101(1):212-222.
13. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 2001, 188(2):143-160.
14. Abdelrahim M., Smith R., Burghardt R., Safe S. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res. 2004, 64(18):6740-6749.
15. Yuan P., Wang L., Wei D., Zhang J., Jia Z., Li Q., Le X., Wang H., Yao J., Xie K. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer 2007, 110(12):2682-2690.
16. Jia Z., Gao Y., Wang L., Li Q., Zhang J., Le X., Wei D., Yao J.C., Chang D.Z., Huang S., Xie K. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res. 2010, 70(3):1111-1119.
17. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3(6):1101-1108.
18. Ständer S., Moormann C., Schumacher M., Buddenkotte J., Artuc M., Shpacovitch V., Brzoska T., Lippert U., Henz B.M., Luger T.A., Metze D., Steinhoff M. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers: mast cells, and epithelial cells of appendage structures. Exp. Dermatol. 2004, 13(3):129-139.
19. Eilers H., Lee S.Y., Hau C.W., Logvinova A., Schumacher M.A. The rat vanilloid receptor splice variant VR.5'sv blocks TRPV1 activation. Neuroreport 2007, 18(10):969-973.
20. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389(6653):816-824.
21. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21(3):531-543.
22. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature 2001, 413(6852):203-210.
23. Schumacher M.A. Transient receptor potential channels in pain and inflammation: therapeutic opportunities. Pain Pract. 2010, 10(3):185-200. 10.1111/j.1533-2500.2010.00358.x.
24. Vay L., Gu C., McNaughton P.A. The thermo-TRP ion channel family: properties and therapeutic implications. Br. J. Pharmacol. 2012, 165(4):787-801.
25. Amaya F., Oh-hashi K., Naruse Y., Iijima N., Ueda M., Shimosato G., Tominaga M., Tanaka Y., Tanaka M. Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res. 2003, 963:190-196.
26. Amaya F., Shimosato G., Nagano M., Ueda M., Hashimoto S., Tanaka Y., Suzuki H., Tanaka M. NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur. J. Neurosci. 2004, 20:2303-2310.
27. Matthews P.J., Aziz Q., Facer P., Davis J.B., Thompson D.G., Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur. J. Gastroenterol. Hepatol. 2004, 16(9):897-902.
28. Breese N.M., George A.C., Pauers L.E., Stucky C.L. Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse. Pain 2005, 115(1-2):37-49.
29. Lania L., Majello B., De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 1997, 29(12):1313-1323.
30. Suske G. The Sp-family of transcription factors. Gene 1999, 238(2):291-300.
31. Bouwman P., Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol. Cell. Endocrinol. 2002, 195(1-2):27-38.
32. Li L., He S., Sun J.M., Davie J.R. Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 2004, 82(4):460-471.
33. Hagen G., Müller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 1994, 13(16):3843-3851.
34. Nielsen S.J., Praestegaard M., Jorgensen H.F., Clark B.F. Different Sp1 family members differentially affect transcription from the human elongation factor 1 A-1 gene promoter. Biochem. J. 1998, 333(Pt 3):511-517.
35. Philipsen S., Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999, 27(15):2991-3000.